{
  "name": "Vertex Pharmaceuticals",
  "slug": "vertex-pharmaceuticals",
  "ticker": "VRTX",
  "fetched_at": "2025-11-09T12:20:21.906048+00:00",
  "news": [
    {
      "title": "Assessing Vertex Pharmaceuticals (VRTX) Valuation as Shares Pause After Strong Multi-Year Gains - simplywall.st",
      "link": "https://news.google.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?oc=5",
      "summary": "<a href=\"https://news.google.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?oc=5\" target=\"_blank\">Assessing Vertex Pharmaceuticals (VRTX) Valuation as Shares Pause After Strong Multi-Year Gains</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">simplywall.st</font>",
      "published": "2025-11-09T05:37:21+00:00",
      "source": "simplywall.st"
    },
    {
      "title": "Why Vertex Skidded Despite Its Beat-And-Raise Quarter - Investor's Business Daily",
      "link": "https://news.google.com/rss/articles/CBMimwFBVV95cUxPTm9kVjVUVVFCTkJyZlZxUmdoWkFPVGl1UVBvbnRaanNlQXBCRm1RYjYyYlVDWi12NEZLa3FHMDJ5S1ZjLXc5VUxZTjV1ZVliRi14MkxkV0ZQcFdCS09tZ1JqSDlWeG1Qb1R6WUNkU0E1TjF2SGpfc3A1SnR3Q2lWb21OalN0bGNhdkJRYmRtVlh3Y21jT25yMXlSTQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimwFBVV95cUxPTm9kVjVUVVFCTkJyZlZxUmdoWkFPVGl1UVBvbnRaanNlQXBCRm1RYjYyYlVDWi12NEZLa3FHMDJ5S1ZjLXc5VUxZTjV1ZVliRi14MkxkV0ZQcFdCS09tZ1JqSDlWeG1Qb1R6WUNkU0E1TjF2SGpfc3A1SnR3Q2lWb21OalN0bGNhdkJRYmRtVlh3Y21jT25yMXlSTQ?oc=5\" target=\"_blank\">Why Vertex Skidded Despite Its Beat-And-Raise Quarter</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Investor's Business Daily</font>",
      "published": "2025-11-04T21:13:00+00:00",
      "source": "Investor's Business Daily"
    },
    {
      "title": "Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMingFBVV95cUxOZWk1bUNZX2p5QWJDVjdidDdtVUdVcVZvYndLbHZXUmNvTEd1Z3J4dS13OUtjQmVQbkZhQndDTXlvQzlZQmNwdUxjbVBhRlV3bm1sTlFoRk45T3R0MnpSQTU4N0J3aGxFU1IxcGNLNDM2cXlhYjlvYjdfRU10c1JHRGR3b2VhNmROYjZGVE96bVI3alp1ZG0yak9sMjZOQQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMingFBVV95cUxOZWk1bUNZX2p5QWJDVjdidDdtVUdVcVZvYndLbHZXUmNvTEd1Z3J4dS13OUtjQmVQbkZhQndDTXlvQzlZQmNwdUxjbVBhRlV3bm1sTlFoRk45T3R0MnpSQTU4N0J3aGxFU1IxcGNLNDM2cXlhYjlvYjdfRU10c1JHRGR3b2VhNmROYjZGVE96bVI3alp1ZG0yak9sMjZOQQ?oc=5\" target=\"_blank\">Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should Know</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-11-07T14:00:03+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "Earnings call transcript: Vertex Q3 2025 beats forecasts, stock gains - Investing.com",
      "link": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxQcnd5RXM0X3pHNWlOZGNOc0F2NDJOMTJOeEtNLUpoME1sbVJSYVF3Y0FzYV9pdDJvUXZaMW42MjBsVS0xM2xrVE83Ny1VVmhrVTE2b2xBQ3J0QlVsOUlxZWdoS0xXQ3RsT0RTQ1JjY1ptdXA2cFNxY0xoOWllUERPNnV1dGxJc2tvTnVXdTF1RlFNaGdOdlYxQlI0ZHBQbXJ2LXR6QmZoeXEtNDJKelJkcy1XNERRMi1VZ1JGSl9qMkU?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiwAFBVV95cUxQcnd5RXM0X3pHNWlOZGNOc0F2NDJOMTJOeEtNLUpoME1sbVJSYVF3Y0FzYV9pdDJvUXZaMW42MjBsVS0xM2xrVE83Ny1VVmhrVTE2b2xBQ3J0QlVsOUlxZWdoS0xXQ3RsT0RTQ1JjY1ptdXA2cFNxY0xoOWllUERPNnV1dGxJc2tvTnVXdTF1RlFNaGdOdlYxQlI0ZHBQbXJ2LXR6QmZoeXEtNDJKelJkcy1XNERRMi1VZ1JGSl9qMkU?oc=5\" target=\"_blank\">Earnings call transcript: Vertex Q3 2025 beats forecasts, stock gains</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Investing.com</font>",
      "published": "2025-11-03T23:40:36+00:00",
      "source": "Investing.com"
    },
    {
      "title": "Vertex touts Journavx launch metrics after novel pain med came up just short of expectations in Q3 - Fierce Pharma",
      "link": "https://news.google.com/rss/articles/CBMingFBVV95cUxOZmI4RmlQSm1jV3ZsMlg2UzAtVDQyekVjMXhEcnhpVG9IREstS2VSVjJtN2Rtb2JfY1pEYTJtcnkta2VWSHJCTzBZazJGM1ZvbUpUNERVRFRGTVdxZmY1ZUdZZWFGVTdjNURUQWpiblQ4U3NsYUN0Vm8tZXE4WnVsRWRadTY2b2xWelg4bFQzcUVGc1A4cEktbGZvWVFwQQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMingFBVV95cUxOZmI4RmlQSm1jV3ZsMlg2UzAtVDQyekVjMXhEcnhpVG9IREstS2VSVjJtN2Rtb2JfY1pEYTJtcnkta2VWSHJCTzBZazJGM1ZvbUpUNERVRFRGTVdxZmY1ZUdZZWFGVTdjNURUQWpiblQ4U3NsYUN0Vm8tZXE4WnVsRWRadTY2b2xWelg4bFQzcUVGc1A4cEktbGZvWVFwQQ?oc=5\" target=\"_blank\">Vertex touts Journavx launch metrics after novel pain med came up just short of expectations in Q3</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Fierce Pharma</font>",
      "published": "2025-11-04T13:40:00+00:00",
      "source": "Fierce Pharma"
    },
    {
      "title": "Vertex Presents Updated Phase 1/2 Data From RUBY-3 Study That Continue to Demonstrate Best-in-Class Potential for Povetacicept in Adults with IgA Nephropathy and Primary Membranous Nephropathy at American Society of Nephrology Kidney Week - Business Wire",
      "link": "https://news.google.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?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMipANBVV95cUxNa0xzSnlwNlV3ZXR3SVdwYzRldGxCYWRHZDcyLUdfYWFLdGpTY0x5QTVGVkRHVXQ1aDB3Q0dORkVjTXRxM3dpZ21xUG9hOXdoOXFOcnpfTlZYeDZuS2dPNlJTZnRldGE3U3VHck9pbGhleFhNYkJQX0xoMmdhMlZZZ09IZHgwU3lHZi1Wbm9OSUJuWTlPMWFPYXpoQ0FiTml1eU5vYm9URjI4M2JSWGp4QXlJY3lJR3VwN0k2VjhJV1JYM1pCNjJPQkREMzhEMGNjR21ENERJZEJUSE9BX3pzRFd0V21jbkNrMkZQN0ZsUkFQSnB4eTlfVDJZWEZWakY2cEh4Um5aakg5RkphakNYcGxqSzZrak1jeGJrT0V5SHIwLVNNWVd0TFdGZC1aeWVVNE40Q2t3MldHOGZRM2kwMVpSV0dmOXZUWXVRODdadU5hbUx0ZXpnRUw0M1hrZll3Y3UzRE1sSW8wdWVjdDNqUk5sdTgxeGVsOWtYdXJTY3lLZVVDdmRseGFRcU03M0NPV21URVNlS1QzWVM1WEYxMFJsWkU?oc=5\" target=\"_blank\">Vertex Presents Updated Phase 1/2 Data From RUBY-3 Study That Continue to Demonstrate Best-in-Class Potential for Povetacicept in Adults with IgA Nephropathy and Primary Membranous Nephropathy at American Society of Nephrology Kidney Week</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Business Wire</font>",
      "published": "2025-11-08T22:15:00+00:00",
      "source": "Business Wire"
    },
    {
      "title": "Home - Vertex Pharmaceuticals",
      "link": "https://news.google.com/rss/articles/CBMiRkFVX3lxTFA5V0I2MlFxR2EzeXBQQUdHWUt1bmVXVXZ1eFRHSUtlZTBnaDZOQjBoa3AzcU81aFZJa1dOSHFFcHRpamxqNVE?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiRkFVX3lxTFA5V0I2MlFxR2EzeXBQQUdHWUt1bmVXVXZ1eFRHSUtlZTBnaDZOQjBoa3AzcU81aFZJa1dOSHFFcHRpamxqNVE?oc=5\" target=\"_blank\">Home</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Vertex Pharmaceuticals</font>",
      "published": "2025-06-02T15:34:51+00:00",
      "source": "Vertex Pharmaceuticals"
    },
    {
      "title": "Vertex Pharmaceuticals Stock is Down 4% Despite Strong Q3 Results - TIKR.com",
      "link": "https://news.google.com/rss/articles/CBMipAFBVV95cUxNWmctaU5ocDNJQkhYeWU1TE9id3plcjdPcE1jR0NYZ2hFMVp6VXJtbzRSMEVRdGo3Z1VYaElRVzlJQ2JOV2F6OFJORlJudEJQMVhzMDExMUZ4Nnc2dlNIaWhjbVJPa2tCVlZzOGVRcmUyVDhfWi1kM2liNTlINmhlN2lRUHZKSEhXWWdCakVkQ0Vhb2l6SElFdzFfdHFJcF9qUy1KaQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMipAFBVV95cUxNWmctaU5ocDNJQkhYeWU1TE9id3plcjdPcE1jR0NYZ2hFMVp6VXJtbzRSMEVRdGo3Z1VYaElRVzlJQ2JOV2F6OFJORlJudEJQMVhzMDExMUZ4Nnc2dlNIaWhjbVJPa2tCVlZzOGVRcmUyVDhfWi1kM2liNTlINmhlN2lRUHZKSEhXWWdCakVkQ0Vhb2l6SElFdzFfdHFJcF9qUy1KaQ?oc=5\" target=\"_blank\">Vertex Pharmaceuticals Stock is Down 4% Despite Strong Q3 Results</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TIKR.com</font>",
      "published": "2025-11-04T10:55:06+00:00",
      "source": "TIKR.com"
    }
  ],
  "product_launches": [
    {
      "title": "Vertex Pharmaceuticals Stock is Down 4% Despite Strong Q3 Results - TIKR.com",
      "link": "https://news.google.com/rss/articles/CBMipAFBVV95cUxNWmctaU5ocDNJQkhYeWU1TE9id3plcjdPcE1jR0NYZ2hFMVp6VXJtbzRSMEVRdGo3Z1VYaElRVzlJQ2JOV2F6OFJORlJudEJQMVhzMDExMUZ4Nnc2dlNIaWhjbVJPa2tCVlZzOGVRcmUyVDhfWi1kM2liNTlINmhlN2lRUHZKSEhXWWdCakVkQ0Vhb2l6SElFdzFfdHFJcF9qUy1KaQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMipAFBVV95cUxNWmctaU5ocDNJQkhYeWU1TE9id3plcjdPcE1jR0NYZ2hFMVp6VXJtbzRSMEVRdGo3Z1VYaElRVzlJQ2JOV2F6OFJORlJudEJQMVhzMDExMUZ4Nnc2dlNIaWhjbVJPa2tCVlZzOGVRcmUyVDhfWi1kM2liNTlINmhlN2lRUHZKSEhXWWdCakVkQ0Vhb2l6SElFdzFfdHFJcF9qUy1KaQ?oc=5\" target=\"_blank\">Vertex Pharmaceuticals Stock is Down 4% Despite Strong Q3 Results</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TIKR.com</font>",
      "published": "2025-11-04T10:55:06+00:00",
      "source": "TIKR.com"
    },
    {
      "title": "Earnings call transcript: Vertex Q3 2025 beats forecasts, stock gains - Investing.com",
      "link": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxQcnd5RXM0X3pHNWlOZGNOc0F2NDJOMTJOeEtNLUpoME1sbVJSYVF3Y0FzYV9pdDJvUXZaMW42MjBsVS0xM2xrVE83Ny1VVmhrVTE2b2xBQ3J0QlVsOUlxZWdoS0xXQ3RsT0RTQ1JjY1ptdXA2cFNxY0xoOWllUERPNnV1dGxJc2tvTnVXdTF1RlFNaGdOdlYxQlI0ZHBQbXJ2LXR6QmZoeXEtNDJKelJkcy1XNERRMi1VZ1JGSl9qMkU?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiwAFBVV95cUxQcnd5RXM0X3pHNWlOZGNOc0F2NDJOMTJOeEtNLUpoME1sbVJSYVF3Y0FzYV9pdDJvUXZaMW42MjBsVS0xM2xrVE83Ny1VVmhrVTE2b2xBQ3J0QlVsOUlxZWdoS0xXQ3RsT0RTQ1JjY1ptdXA2cFNxY0xoOWllUERPNnV1dGxJc2tvTnVXdTF1RlFNaGdOdlYxQlI0ZHBQbXJ2LXR6QmZoeXEtNDJKelJkcy1XNERRMi1VZ1JGSl9qMkU?oc=5\" target=\"_blank\">Earnings call transcript: Vertex Q3 2025 beats forecasts, stock gains</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Investing.com</font>",
      "published": "2025-11-03T23:40:36+00:00",
      "source": "Investing.com"
    },
    {
      "title": "Strong Product Launches and Upbeat Guidance Could Be a Game Changer for Vertex Pharmaceuticals (VRTX) - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMijgFBVV95cUxNOFZFNHZzSk1rSnJWVTEwWExLd1FvWVBPUkVkTV9TRG1oUWdTbWgzbWNkdlA3MkVLNmVra3NUUWhBQWFXZ3c5LVNxZFRkWDhkMUZ1QVlUXzg3ZEZwOHY3TTRjMEYxUjlwZFhYVW84QUVXX0lQaTZVbDN4Qk5WM1NQX0EwSVJXZ2piZXl4d3ZB?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMijgFBVV95cUxNOFZFNHZzSk1rSnJWVTEwWExLd1FvWVBPUkVkTV9TRG1oUWdTbWgzbWNkdlA3MkVLNmVra3NUUWhBQWFXZ3c5LVNxZFRkWDhkMUZ1QVlUXzg3ZEZwOHY3TTRjMEYxUjlwZFhYVW84QUVXX0lQaTZVbDN4Qk5WM1NQX0EwSVJXZ2piZXl4d3ZB?oc=5\" target=\"_blank\">Strong Product Launches and Upbeat Guidance Could Be a Game Changer for Vertex Pharmaceuticals (VRTX)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-08-22T07:00:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "VRTX Q3 Deep Dive: New Product Launches and Pipeline Progress Shape Outlook - The Globe and Mail",
      "link": "https://news.google.com/rss/articles/CBMi8gFBVV95cUxPNHdyRV85OXJ0VDQxRkYtTUN2NEtERzVJZ0pzRVBQYVNObWV6ZFpScjFJQnVSeWFhMVdjT0FUM0tSNUJjMHY4WndXZV9JaGZjbnpzdGlRYV91MGNYSkZtbkJWV0xVZlFZbUJMazlmMl9ETV8yVEdnTEI0SURUeER4M1doWVdBWW1NS3FlUmF6alVyaHNvYUlRZXlQNXhQS3p2ZThHS1dDNVVBRXAtYWhWZGVVeDg1WFdkQzFVZHpvanRtc1JXajFQNEhJb2FkVEVRZXB2QnFKM3J3dzMteFNUSDRKUTVNSy1pMFl5WXdMTDd3Zw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMi8gFBVV95cUxPNHdyRV85OXJ0VDQxRkYtTUN2NEtERzVJZ0pzRVBQYVNObWV6ZFpScjFJQnVSeWFhMVdjT0FUM0tSNUJjMHY4WndXZV9JaGZjbnpzdGlRYV91MGNYSkZtbkJWV0xVZlFZbUJMazlmMl9ETV8yVEdnTEI0SURUeER4M1doWVdBWW1NS3FlUmF6alVyaHNvYUlRZXlQNXhQS3p2ZThHS1dDNVVBRXAtYWhWZGVVeDg1WFdkQzFVZHpvanRtc1JXajFQNEhJb2FkVEVRZXB2QnFKM3J3dzMteFNUSDRKUTVNSy1pMFl5WXdMTDd3Zw?oc=5\" target=\"_blank\">VRTX Q3 Deep Dive: New Product Launches and Pipeline Progress Shape Outlook</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">The Globe and Mail</font>",
      "published": "2025-11-04T22:05:14+00:00",
      "source": "The Globe and Mail"
    },
    {
      "title": "Vertex Pharmaceuticals Reports Strong Q3 2025 Results - TipRanks",
      "link": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxNMFM4M1o1WTM2UW5zNG1xX0NYMm9vZUZXN3ZpRUZTb21mSmVZWXZaQzdKYVE2Znc3WWxzck5YcVlRWklKeFV3TjdZTXB1bzBtSHJPeWR2dVlwcmZCN2o0MVFHRXR6bHZZSkFDMkFVN1hObWxxSUl5S3cySG9NSEgyUVBybkttaWRiRUZKYWtXNGpGVnQzRjkyTW5Wd0EwalRGdzRRWF9GeFc?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiqAFBVV95cUxNMFM4M1o1WTM2UW5zNG1xX0NYMm9vZUZXN3ZpRUZTb21mSmVZWXZaQzdKYVE2Znc3WWxzck5YcVlRWklKeFV3TjdZTXB1bzBtSHJPeWR2dVlwcmZCN2o0MVFHRXR6bHZZSkFDMkFVN1hObWxxSUl5S3cySG9NSEgyUVBybkttaWRiRUZKYWtXNGpGVnQzRjkyTW5Wd0EwalRGdzRRWF9GeFc?oc=5\" target=\"_blank\">Vertex Pharmaceuticals Reports Strong Q3 2025 Results</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">TipRanks</font>",
      "published": "2025-11-04T03:56:57+00:00",
      "source": "TipRanks"
    }
  ],
  "stock": {
    "ticker": "VRTX",
    "currency": "USD",
    "latest": {
      "date": "2025-11-07",
      "close": 409.4700012207031
    },
    "history": [
      {
        "date": "2025-10-30",
        "close": 419.8900146484375
      },
      {
        "date": "2025-10-31",
        "close": 425.57000732421875
      },
      {
        "date": "2025-11-03",
        "close": 426.0
      },
      {
        "date": "2025-11-04",
        "close": 421.6700134277344
      },
      {
        "date": "2025-11-05",
        "close": 417.0
      },
      {
        "date": "2025-11-06",
        "close": 416.25
      },
      {
        "date": "2025-11-07",
        "close": 409.4700012207031
      }
    ],
    "name": "Vertex Pharmaceuticals Incorpor"
  }
}